— Know what they know.
Not Investment Advice

NAYA NASDAQ

NAYA Biosciences, Inc.
1W: -9.2% 1M: -7.3% 3M: -61.0% 1Y: -84.0% 3Y: -99.5%
$2.20
Last traded 2025-05-22 — delisted
NASDAQ · Healthcare · Medical - Devices · $1.5M mcap · 336490 float · 463.72% daily turnover · Short 42% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.5M
52W Range1.38-17.04
Volume83,057
Avg Volume1,560,367
Beta2.04
Dividend—
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOSteven M. Shum
Employees30
SectorHealthcare
IndustryMedical - Devices
IPO Date2020-11-02
5582 Broadcast Court
Sarasota 34240
US
About NAYA Biosciences, Inc.

INVO Bioscience operates as a medical device company, focusing on the development and provision of tools and solutions for diagnosing infertility. Their primary innovation is INVOcell, a unique reproductive technology designed to allow both fertilization and the early development of an embryo to happen inside the woman's own body.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms